NASDAQ: BTTX - Better Therapeutics, Inc.

Lønnsomhet i seks måneder: -99.12%
Sektor: Healthcare

Kampanjeplan Better Therapeutics, Inc.

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet

Better Therapeutics, Inc., a prescription digital therapeutics company, develops a form of cognitive behavioral therapy to address the causes of cardiometabolic diseases. The company's lead product candidate is BT-001, an investigational PDT platform to treat type 2 diabetes. It also develops software-based prescription digital therapeutics platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions.

flere detaljer
In addition, the company's clinical development candidates are intended to treat cardiometabolic diseases, including type 2 diabetes, hypertension, hyperlipidemia, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, and chronic kidney disease. Its product pipeline also includes BT-002, which intends glycemic control for hypertension; BT-003 to reduce LDL cholesterol in patients with hyperlipidemia; and BT-004, which intends to explore the impact of treatment on liver health in patients with non-alcoholic steatohepatitis/non-alcoholic fatty liver disease. The company was founded in 2015 and is headquartered in San Francisco, California.
Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

EBITDA -0.0057
EV/EBITDA -0.7443
IPO date 2021-10-28
ISIN US08773T1043
Industry Biotechnology
P/BV 3.35
Sector Health Care
Валюта usd
Валюта отчета usd
Выручка 1.8E-5
Сайт https://www.bettertx.com
Цена ао 0.0137
Число акций ао 0.02356 млрд
Prisendring per dag: 0% (0.0001)
Prisendring per uke: 0% (0.0001)
Prisendring per måned: 0% (0.0001)
Prisendring over 3 måneder: 0% (0.0001)
Prisendring over seks måneder: -99.12% (0.0113)
Prisendring per år: -99.95% (0.195)
Prisendring over 3 år: -100% (4.65)
Prisendring over 5 år: 0% (0.0001)
Prisendring over 10 år: 0% (0.0001)
Prisendring siden begynnelsen av året: 0% (0.0001)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 0 0
P/BV -35.64 0
P/E 0 0
EV/EBITDA -0.8149 0
Total: 2.5

Effektivitet

Navn Betydning Karakter
ROA, % -107.6 0
ROE, % -221.99 0
Total: 0

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA -0.389 10
Total: 9.8

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % 0 0
Lønnsomhet Ebitda, % 523.39 10
Lønnsomhet EPS, % 217.59 10
Total: 8
Flere detaljer

Institusjoner Volum Dele, %
MMCAP International, Inc. SPC 356270 0.71
Citadel Advisors Llc 216165 0.43
Vanguard Group Inc 198154 0.4
Geode Capital Management, LLC 168821 0.34
Millennium Management LLC 128749 0.26
Blackrock Inc. 88635 0.18
Capital Investment Advisory Services, LLC 71000 0.14
State Street Corporation 58600 0.12
Susquehanna International Group, LLP 38057 0.08
Corient Private Wealth LLC 29180 0.06



Veileder Stillingstittel Betaling Fødselsår
Mr. David P. Perry M.B.A. Co-Founder & Executive Chairman 260k 1968 (57 år)
Mr. Frank L. Karbe CEO, Interim CFO, President & Director 533.37k 1968 (57 år)
Dr. Mark A. Berman M.D. Chief Medical Officer 573.75k 1976 (49 år)
Ms. Kristin Wynholds Chief Product Officer 519.07k 1973 (52 år)
Mr. Andres Camacho Senior VP of Technology & Head of Engineering N/A
Ms. Angela Willis Senior Vice President of Market Access N/A
Leslie Miller Controller N/A
Ms. Jessica Meng Chief Commercial Officer N/A

Adresse: United States, San Francisco. CA, 548 Market Street - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.bettertx.com